News
Momentum Grows for These 3 Healthcare Stocks
Today’s stock market has brought about a set of distracting indicators and methods to analyze a potential trade—or investment—opportunity, some of which might be accurate in a completely binary
AI Pharma: 2 Paths to AI-Powered Drug Investment
The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence (AI). Traditionally, drug development has been a lengthy, costly, and
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter, Abbott
Beyond Rigetti: Top 3 Quantum Computing Stock Picks
Just when you may have finally gotten your head around the opportunity in artificial intelligence (AI), a new investment opportunity has popped up. Quantum computing is the latest “new thing”
UnitedHealth Group Pulls Back Into Another Healthy Opportunity
UnitedHealth Group (NYSE: UNH) stock price is pulling back from highs set last year, presenting a healthy opportunity for investors. Although the outlook for revenue growth has dimmed, the
Vertex's Pain Drug: Big Pharma's Next Major Success?
Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing treatments for cystic fibrosis (CF). Vertex is strategically expanding into the
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
As 2025 kicks off with a volatile start, many investors are likely feeling the pressure of heightened uncertainty. The S&P 500 and other major indices are down year-to-date, led by sharp declines
Can Integrated Healthcare Stocks Succeed in Public Markets?
America’s health insurance industry continues to face scrutiny after it was thrust into the headlines after the murder of UnitedHealth Group Inc. (NYSE: UNH) owned United Healthcare CEO Brian
3 Stocks With Strong Capital Returns and Insider Buying Signals
Capital returns are a driving force for markets and central to the stocks on this list. These stocks pay significant dividends, repurchase shares robustly, or both, and insider buying is strong
BioNTech gibt auf der 43. J.P. Morgan Healthcare-Konferenz Updates zur Geschäfts- und Pipeline-Entwicklung
- BioNTech fokussiert sich in der Umsetzung der Onkologie-Strategie auf tumorübergreifende (Pan-Tumor-) Therapieansätze basierend auf Kombinationen mit BNT327/PM8002 sowie den
How Cigna Remains at the Top of the Health Insurance Food Chain
The health insurance industry has received a lot of backlash over its managed care practices that bog down providers with pre-authorizations and rampant medical claim denials. The rise in medical
Top 3 Stocks Seeing a Spike in Call Option Volume
Volume is what drives the entire market, and that is a fact that often gets lost in the sea of indicators, patterns, and trend lines that dominate today’s concept of analysis. However, most
3 Stocks Helping to Bring AI to Healthcare
Artificial intelligence stocks are expected to continue showing strong growth in 2025. Much of the attention focuses on the opportunity that comes from the buildout of data centers. But a
Pfizer: 4 Reasons to Buy This Stock
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) stock is trading back down near its pandemic lows. Every time it attempts to climb over the $30 mark, something causes shares to slide right back down
Vertex im IDC MarketScape 2024 als Leader für weltweite SaaS- und Cloud-fähige Software zur Steuerautomatisierung für Großunternehmen, KMU´s und VAT ausgezeichnet
KING OF PRUSSIA, Pa., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) („Vertex“ oder das „Unternehmen“), ein globaler Anbieter von Steuertechnologielösungen, wurde in drei IDC
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast
Pfizer (NYSE:PFE), which develops and sells biopharmaceutical products worldwide, closed today's session (Dec. 16) at $25.53, down 3.41%. Trading volume reached 108.1 million shares, almost 60%
2 Dividend Stocks to Double Up on Right Now
A volatile trading environment and high inflation should not deter investors from the stock market. These challenges will eventually subside, and equities have performed well over the long term
This Dividend Stock Just Hit a Major Milestone. Time to Buy?
Medtronic (NYSE: MDT), a medical device specialist, has performed well this year. That's despite the threat of tariffs, which are having a material impact on its earnings. However, its financial
My Top 3 Healthcare Stocks to Buy in 2026
After trailing broader equities over the past few years, will the healthcare sector finally bounce back in 2026? It's hard to predict those things.
No matter what happens to the industry, though
2 Reasons to Buy Regeneron Stock Like There's No Tomorrow
Several headwinds have pushed Regeneron's (NASDAQ: REGN) shares lower over the past year and a half. However, the company is bouncing back and has performed well in recent months. What's more, there
Forget Teladoc and Buy This Healthcare Stock Instead
Telemedicine leader Teladoc Health (NYSE: TDOC) has been struggling for several years. The company's services are no longer experiencing the kind of demand they did during the pandemic years
2 Healthcare Stocks to Buy Ahead of the New Year
Healthcare stocks as a group have not performed on par with broader equities this year. However, that doesn't mean investors should avoid the sector altogether. Many healthcare companies appear to
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
Looking for great stocks to be had at a bargain? Even though broader equities have performed well this year, there are companies, particularly in sectors that haven't kept up with the rest of the
Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.
It now seems so long ago that Pfizer (NYSE: PFE) became the first company in the biopharmaceutical industry to generate over $100 billion in annual sales. The drugmaker achieved this milestone
The Best Turnaround Stock to Invest $1,000 in Right Now
Even very well-run companies will eventually fall upon hard times. That's the backstory you need to keep in mind when you examine Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE). Here's why